Nalan Gülşen Ünal

Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies

David T. Rubin, Jessica R. Allegretti, Julián Panés et al. · The Lancet · 2024 · 62 citations · Full text

Placebo-controlled Induction, Gastroenterology, Pathology +6

Malnutrition and sarcopenia are prevalent among inflammatory bowel disease patients with clinical remission

Nalan Gülşen Ünal, Nevin Oruç, Okşan Tomey et al. · European Journal of Gastroenterology & Hepatology · 2021 · 48 citations

Chronic Hypoxemia Leads to Reduced Serum IGF-I Levels in Cyanotic Congenital Heart Disease

Bumin Nuri Dündar, A Saylam, Nalan Gülşen Ünal et al. · Journal of Pediatric Endocrinology and Metabolism · 2000 · 45 citations

Nutrition, Heart Failure, Pediatric Heart Disease +16

Face‐to‐face interviews versus Internet surveys: Comparison of two data collection methods in the Rome foundation global epidemiology study: Implications for population‐based research

Ami D. Sperber, Serhat Bor, Xuicai Fang et al. · Neurogastroenterology & Motility · 2023 · 28 citations · Full text

Epigenetics of Inflammatory Bowel Diseases

Murat Törüner, Nalan Gülşen Ünal · The Turkish Journal of Gastroenterology · 2023 · 27 citations · Full text

Histone Modifications, Chronic Inflammatory Diseases, Epigenetic Change +17